IL4 and psoriasis: Filomena Russo et al [15] also report a case of psoriasis during treatment of PN with dupilumab (IL-4 inhibitor) after 4 weeks, but authors claim that the pathophysiology of psoriasis induced after treatment with dupilumab is unclear.